Vaxcyte

Executive Director Quality Assurance, External Manufacturing

Vaxcyte  •  $300k - $350k/yr  •  San Carlos, CA (Hybrid)  •  19 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Join our Mission to Protect Humankind!

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.

The Executive Director, Quality Assurance, External Manufacturing is responsible for leading the External Manufacturing Quality function and executing the quality strategy across Vaxcyte’s global network of Contract Development and Manufacturing Organizations (CDMOs) and external partners. In a highly outsourced operating model, this role ensures that externally executed GMP activities are compliant with global regulatory requirements and Vaxcyte quality standards, supporting product quality, supply continuity, and regulatory readiness.

This leader drives a proactive, risk-based quality approach and implements scalable systems, governance, and partnerships to enable operational excellence across the external network, supporting clinical development, BLA readiness, and commercial supply. The Executive Director owns external quality performance and operational decision-making within the function, while escalating critical risks and aligning with VP-level strategy. This role requires strong cross-functional leadership and the ability to influence internal and external stakeholders in a highly matrixed environment.

Essential Functions:

  • Own quality performance across the external network, ensuring compliance, supply continuity, and effective management of quality risk, with escalation of critical risks to VP-level as appropriate.
  • Provide end-to-end QA leadership for externally executed GxP activities, including manufacturing and release of drug substance, drug product, components, and critical raw materials.
  • Serve as the senior QA leader for external operations, representing Quality in cross-functional and executive forums, and influencing decisions across Technical Operations, CMC, Regulatory, and Supply Chain.
  • Establish and maintain strategic partnerships with external partners, driving accountability, performance management, and continuous improvement.
  • Lead quality governance across the external network, including KPIs, escalation pathways, and risk-based oversight models focused on critical processes and high-risk partners.
  • Oversee and drive resolution of complex, cross-organizational quality issues, ensuring robust investigations, root cause analysis, and sustainable CAPAs.
  • Provide oversight and decision authority for batch disposition and product release, ensuring timely, compliant supply of clinical and commercial materials.
  • Drive inspection readiness across the external network, including PAI and global health authority inspections, and serve as a key QA representative during inspections.
  • Provide strategic QA leadership for technology transfer, process validation, and lifecycle management across external sites.
  • Build, lead, and develop a high-performing External Quality organization, including talent development, succession planning, and organizational scalability.
  • Champion a strong quality culture across internal teams and external partners, reinforcing accountability, transparency, and continuous improvement.

Requirements:

BS/BA required, with a minimum of 16 years of progressive experience in Quality Assurance within biopharmaceuticals, including significant leadership in external manufacturing and CDMO oversight, vaccines experience desirable. Other combinations of education and/or experience may be considered.

  • Deep expertise in GMP regulations, FDA and global regulatory expectations, and ICH guidelines
  • Extensive experience operating within a highly outsourced/CDMO-based manufacturing model
  • Proven track record of leading complex external quality networks, driving performance and outcomes without direct authority
  • Strong experience supporting technology transfer, process validation, and lifecycle management across multiple external sites
  • Demonstrated success in inspection readiness and regulatory inspections, including pre-approval inspections (PAIs)
  • Experience establishing governance frameworks, and performance metrics for external partners
  • Strong background in risk management and quality systems, with the ability to apply risk-based decision-making in a GxP environment
  • Proven ability to influence at the executive level, driving alignment across cross-functional teams and external partners
  • Demonstrated experience building, leading, and scaling high-performing teams in a complex, fast-paced environment
  • Strong business acumen, with the ability to balance quality, compliance, and supply continuity to supportclinical and commercial objectives

Key Competencies

  • Strategic Leadership in Outsourced Models
  • External Partner Governance & Influence
  • Risk-Based Quality Oversight
  • Regulatory Inspection Readiness (PAI Focus)
  • Executive Communication & Cross-Functional Leadership
  • Complex Problem Solving & Decision-Making
  • Organizational Development & Talent Leadership
Reports to: Vice President, Quality Assurance
Location: San Carlos, CA
Work Arrangement: Hybrid (minimum of 2-3 days per week)
Compensation:
The compensation package will be competitive and includes comprehensive benefits and an equity component.
Salary Range: $300,000 - $350,000 (SF Bay Area). Salary ranges for non-California locations may vary.
Relocation:
This role is not eligible for relocation assistance.
#LI-JN1

We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.

Vaxcyte

About Vaxcyte

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. We are developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

VAX-31, our 31-valent pneumococcal conjugate vaccine (PCV) candidate advancing to a Phase 3 adult clinical program and currently being evaluated in a Phase 2 infant clinical program, is being developed for the prevention of invasive pneumococcal disease (IPD) in adults and infants and is the broadest-spectrum PCV candidate in the clinic today. VAX-24, our 24-valent PCV candidate, is designed to cover more serotypes than any infant PCV on-market and is currently being evaluated in a Phase 2 infant study. Both VAX-31 and VAX-24 are designed to improve upon the standard-of-care PCVs by covering the serotypes in circulation that are responsible for a significant portion of IPD and are associated with high case-fatality rates, antibiotic resistance and meningitis, while maintaining coverage of previously circulating strains that are currently contained through continued vaccination practice.

We are re-engineering the way highly complex vaccines are made. Unlike conventional cell-based approaches, our system for producing difficult-to-make proteins and antigens is intended to accelerate our ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits.

In addition to our PCV franchise, our pipeline includes early-stage programs targeting Group A Strep, periodontitis and Shigella. At Vaxcyte, we are driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.

Industry
Biotech & Life Sciences
Company Size
201-500 employees
Headquarters
San Carlos, California
Year Founded
2013
Social Media